platoseedplatoseed
High-precision, closed-loop neuromodulation devices
We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.
Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation (DBS) devices aimed at treating neurological disorders by delivering targeted, responsive neural stimulation. The technology combines micro/nano-fabricated electrode leads, a readout/control chip, and a machine learning data-analysis platform to adjust stimulation based on neural activity.
The product consists of ultra-small micro-electrode leads capable of sensing neural activity and providing high-spatial-resolution stimulation, paired with an electronic readout/control chip to manage stimulation. A machine learning driven data analysis platform analyzes recorded neural signals to automatically adjust stimulation parameters in real time, enabling a closed-loop DBS system that aims to deliver precise targeting while reducing off-target effects and re-programming visits.
Who it’s for: Healthcare providers and researchers treating neurological disorders such as Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy; neuromodulation clinics and academic medical centers involved in DBS research and therapy.
No explicit funding/hiring details provided; product description and roadmap imply R&D/early-stage development in hardware and ML platform
Ingrid van Welie, PhD, is the Founder and CEO of Torpedo Therapeutics. Ingrid is a neuroscientist and biophysicist and is focused on developing and commercializing new technologies for sensing and modulating the electrical properties of neurons in the brain.
Formerly “Neural Dynamics Technologies LLC” · why startups rename →
Bringing non-invasive brain stimulation from the hospital to the home
Cell-specific genetic medicines
